Guangzhou Baiyunshan Pharmaceutical Limited (GZPHF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Guangzhou Baiyunshan Phar...

    OTC: GZPHF · Real-Time Price · USD
    2.34
    0.00 (0.00%)
    At close: May 02, 2025, 1:42 PM
    2.34
    0.00%
    After-hours: Sep 09, 2025, 08:00 PM EDT

    Guangzhou Baiyunshan Pharmaceutical Income Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 74.99B 75.52B 70.79B 69.01B
    Cost of Revenue
    		 62.47B 61.33B 57.51B 55.78B
    Gross Profit
    		 12.52B 14.19B 13.28B 13.23B
    Operating Income
    		 3.6B 5.12B 5.07B 4.79B
    Interest Income
    		 404.31M 486.34M 626.79M 563.87M
    Pretax Income
    		 3.61B 5.11B 5.04B 4.72B
    Net Income
    		 2.84B 4.06B 3.97B 3.72B
    Selling & General & Admin
    		 3B 3.36B 6.43B 6.43B
    Research & Development
    		 763.77M 782.14M 819.45M 874.72M
    Other Expenses
    		 5.16B 4.92B 1.48B 1.54B
    Operating Expenses
    		 8.92B 9.07B 8.73B 8.85B
    Interest Expense
    		 418.15M 470.09M 434.41M 417.83M
    Selling & Marketing Expenses
    		 2.43B 2.76B 5.88B 5.95B
    Cost & Expenses
    		 71.4B 70.39B 66.24B 64.63B
    Income Tax Expense
    		 606.85M 851.17M 789.87M 754.09M
    Shares Outstanding (Basic)
    		 1.63B 1.63B 1.63B 1.63B
    Shares Outstanding (Diluted)
    		 1.63B 1.63B 1.63B 1.63B
    EPS (Basic)
    		 1.74 2.49 2.44 2.29
    EPS (Diluted)
    		 1.74 2.49 2.44 2.29
    EBITDA
    		 4.9B 6.46B 6.15B 5.76B
    EBIT
    		 4.03B 5.56B 5.48B 5.04B
    Depreciation & Amortization
    		 875.24M 929.44M 793.66M 720.52M

    Add to Watchlist